RE: onc interview8 Jun 2021 13:33
Thanks for sharing. That just got me excited about the growth prospects. The numbers and everything he is talking about is really positive. What a strong investor backing as well:
No of ordinary shares %
Balderton Capital III, LP (1) 6,813,196 shares 9.9%
Blind Trust (Richard Sharp) 4,447,000 shares 6.4%
Chelverton Asset Management 3,889,391 shares 5.6%
Credit Suisse 3,877,404 shares 5.6%
Dr Adam M Hill (2) 3,537,539 shares 5.1%
Genostics Company Ltd 3,266,770 shares 4.7%
Mr Timothy Brian Bunting 2,956,717shares 4.3%
Barclays 2,576,748 shares 3.7%
Hargreaves Lansdown Asset Management 2,122,185 shares 3.1%